S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

PLX Protalix BioTherapeutics Inc

1.145

-0.055 (-4.58%)

Last Updated: 02:34:31

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

Protalix BioTherapeutics (AMEX:PLX)
Historical Stock Chart
From Mar 2024 to May 2024

Click Here for more Protalix BioTherapeutics Charts.

Protalix BioTherapeutics (AMEX:PLX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Protalix BioTherapeutics Charts.

Protalix Biotherapeutics, Inc. News

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Tuesday 2 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 26 December 2023 (4 months ago) • Edgar (US Regulatory)

Levicept Appoints Eliot Forster as CEO
Thursday 30 November 2023 (5 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 6 November 2023 (6 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 6 November 2023 (6 months ago) • Edgar (US Regulatory)

Upcoming Earnings Release Paired With Price Target Raise Sends Stock Soaring
Wednesday 1 November 2023 (6 months ago) • AllPennyStocks.com

Form 4 - Statement of changes in beneficial ownership of securities
Friday 20 October 2023 (6 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 4 October 2023 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 4 October 2023 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 4 October 2023 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 4 October 2023 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 16 September 2023 (7 months ago) • Edgar (US Regulatory)

More Protalix Biotherapeutics, Inc. News Articles

JP Morgan Chase

Verizon Communications

S&P ASX 300 Metals and M...

Woodside Petroleum

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions